[Novel monoclonal antibodies for the treatment of malignant lymphomas]
- PMID: 21897067
[Novel monoclonal antibodies for the treatment of malignant lymphomas]
Similar articles
-
Monoclonal antibody therapy of leukaemias and lymphomas.Expert Opin Biol Ther. 2005 Sep;5(9):1225-43. doi: 10.1517/14712598.5.9.1225. Expert Opin Biol Ther. 2005. PMID: 16120052 Review.
-
Monoclonal antibody therapy for central nervous system lymphomas: an emerging treatment paradigm.Expert Opin Pharmacother. 2005 Jun;6(7):1107-14. doi: 10.1517/14656566.6.7.1107. Expert Opin Pharmacother. 2005. PMID: 15957965 Review.
-
[Therapeutic monoclonal antibodies in onco-hematology].Med Sci (Paris). 2009 Dec;25(12):1085-9. doi: 10.1051/medsci/200925121085. Med Sci (Paris). 2009. PMID: 20035683 Review. French.
-
A review of monoclonal antibody therapies in lymphoma.Crit Rev Oncol Hematol. 2016 Jan;97:72-84. doi: 10.1016/j.critrevonc.2015.08.014. Epub 2015 Aug 10. Crit Rev Oncol Hematol. 2016. PMID: 26318093 Review.
-
Variable contribution of monoclonal antibodies to ADCC in patients with chronic lymphocytic leukemia.Leuk Lymphoma. 2009 Aug;50(8):1361-8. doi: 10.1080/10428190903026500. Leuk Lymphoma. 2009. PMID: 19562616
Cited by
-
Potentiating antilymphoma efficacy of chemotherapy using a liposome for integration of CD20 targeting, ultra-violet irradiation polymerizing, and controlled drug delivery.Nanoscale Res Lett. 2014 Aug 28;9(1):447. doi: 10.1186/1556-276X-9-447. eCollection 2014. Nanoscale Res Lett. 2014. PMID: 25221463 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources